Next, GNMs come into contact with the surface of cancer cells, either passively or by active targeting; for example, when coupled to ligands for folate, transferrin, or epidermal growth factor receptors overexpressed on tumor cells [16,33,34], or by magnetic targeting [35]. The gene discussed is TF; the disease is neoplasm.